How many drugs treat Hemorrhaging in Hemophilia?

Drug Landscape tracks 3 marketed treatments for Hemorrhaging in Hemophilia (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/hemorrhaging-in-hemophilia.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Hemorrhaging in Hemophilia — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hemorrhaging in Hemophilia (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Hemorrhaging in Hemophilia, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Cyklokapron	TRANEXAMIC ACID	Exela Pharma	Antifibrinolytic Agent [EPC]	Plasminogen	1986-01-01
Amchafibrin	Amchafibrin	Fundación Pública Andaluza Progreso y Salud		Plasminogen
transamin	transamin	Erzincan Military Hospital		Plasminogen

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Erzincan Military Hospital · 1 drug in Hemorrhaging in Hemophilia
Exela Pharma · 1 drug in Hemorrhaging in Hemophilia
Fundación Pública Andaluza Progreso y Salud · 1 drug in Hemorrhaging in Hemophilia

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Hemorrhaging in Hemophilia:

Cite this brief

Drug Landscape (2026). Hemorrhaging in Hemophilia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/hemorrhaging-in-hemophilia. Accessed 2026-06-10.

Hemorrhaging in Hemophilia full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing